Lembas

Lembas Overview

Lembas develops natural, clinically validated bioactive ingredients for functional foods and supplements, using an AI-powered discovery platform. Its lead product, GLP-1 Edge™, is a food-grade peptide that enhances the body’s GLP-1 response to support appetite regulation and metabolic health. Designed for seamless integration into formats like bars, shakes, and supplements, it enables natural weight management without pharmaceutical intervention. The company’s proprietary AI platform accelerates the design of targeted peptides, leveraging patent-pending academic technology to expand into additional health applications. Lembas combines computational biology with food science to bring precision bioactives into everyday nutrition.

Cumulative Funding Raised Over Time ($)

Latest News

Jun 22, 2025 · en.globes.co.il

growth-positive

Israeli startup Lembas unveils food additive for slimming

Israeli foodtech startup Lembas has emerged from stealth, announcing a $3.6 million pre-seed financing round led by FLORA Ventures and others. The company has developed GLP-1 Edge, a bioactive peptide aimed at regulating appetite and metabolism, which it plans to offer as a pill and integrate into food products. Lembas aims to provide an alternative to injectable GLP-1 drugs like Ozempic, targeting those who prefer non-injection methods. The product is in the R&D stage, with plans to enter the market by 2027, contingent on partnerships with food and supplement companies. The company uses AI technology to discover impactful food ingredients.

Product StageInvestment

Jun 11, 2025 · www.prnewswire.com

growth-positive

Lembas Emerges from Stealth with Breakthrough Discovery in Natural GLP-1 for Weight Management

Lembas, an AI-driven bioactive peptide discovery company, has successfully raised $3.6 million in a pre-seed funding round led by FLORA Ventures. The company has emerged from stealth mode with a breakthrough in activating the GLP-1 hormone, which regulates appetite and metabolism. Lembas aims to address the $560 billion global weight management industry with its GLP-1 Edge solution, which naturally regulates appetite. The company plans to scale up and commercialize its product, expand its AI discovery platform, and deepen commercial agreements in the food and supplements industry. Lembas is backed by a university-patented technology and led by a team of experienced entrepreneurs and scientists.

InvestmentProduct StageExpandPartners

Funding

Team Members

2

Employees: 1-10

Web & Social Links

Locations

Tel Mond, Israel

Sheffield, UK

Photos & Videos

No files yet

Lembas Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info